Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02645422Unknown

Genetic Determinants and Clinical Consequences of Early-onset Severe Obesity

Role: collaborator

NCT04533282Unknown

Epitranscriptomic Blood Biomarkers for Coronary Artery Disease - A Prospective Cohort Study (IHD-EPITRAN)

Role: collaborator

NCT01803776Not ApplicableUnknown

The Physical Activity and Nutrition in Children (PANIC) Study

Role: collaborator

NCT04073927Not ApplicableUnknown

Effect of Butyrate on Inflammation and Albuminuria in Patients With Albuminuria, Type 1 Diabetes and Intestinal Inflammation

Role: collaborator

NCT02294370Completed

Variation of Glucose Values at Early Stages of Diabetes - Continuous Glucose Monitoring

Role: lead

NCT02131701Not ApplicableCompleted

PPP-Botnia Exercise Intervention Study

Role: lead

All 6 trials loaded